Natera, Inc.: These Are The 6 Biggest Factors Impacting Its Performance In 2025 &Beyond! 

Natera, Inc. reported a significant quarter for Q3 2024, demonstrating positive developments and some challenges inherent in its operations. The company achieved a notable revenue increase, reaching $439.8 million, marking a 64% rise compared to the previous year. This growth is largely attributed to robust performance across its testing portfolio, particularly within the oncology sector, where the company performed around 137,000 oncology tests, reflecting a substantial 54% year-over-year increase.